Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Cancer Research
|
August 1, 1983
Mitoxantrone in patients with acute leukemia in relapse
P A Paciucci, T Ohnuma, J Cuttner, et al.
Haematologia
|
January 1, 1982
Management of leukaemia-associated disseminated intravascular coagulation (DIC)
C K Williams, B Fernbach, J Cuttner, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia
J Cuttner, J F Holland, L Norton, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1975
Panel 3: phase III investigations
D L Azarnoff, W B Abrams, J Cuttner, et al.
Leukemia
|
December 1, 1989
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia
V Najfeld, J Cuttner, A Figur, et al.
British Journal of Haematology
|
February 1, 1989
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years
H D Preisler, K Anderson, K Rai, et al.
American Journal of Hematology
|
December 12, 1997
Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia
P A Paciucci, J Cuttner, A Gottlieb, et al.
The American Journal of Medicine
|
May 1, 1980
Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study
R J Meyer, P P Ferreira, J Cuttner, et al.
The American Journal of Medicine
|
October 1, 1980
Association of monocytic leukemia in patients with extreme leukocytosis
J Cuttner, M S Conjalka, M Reilly, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1987
Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications
C K Williams, J Cuttner, T Ohnuma, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Cancer Research
|
August 1, 1983
Mitoxantrone in patients with acute leukemia in relapse
P A Paciucci, T Ohnuma, J Cuttner, et al.
Haematologia
|
January 1, 1982
Management of leukaemia-associated disseminated intravascular coagulation (DIC)
C K Williams, B Fernbach, J Cuttner, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia
J Cuttner, J F Holland, L Norton, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1975
Panel 3: phase III investigations
D L Azarnoff, W B Abrams, J Cuttner, et al.
Leukemia
|
December 1, 1989
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia
V Najfeld, J Cuttner, A Figur, et al.
British Journal of Haematology
|
February 1, 1989
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years
H D Preisler, K Anderson, K Rai, et al.
American Journal of Hematology
|
December 12, 1997
Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia
P A Paciucci, J Cuttner, A Gottlieb, et al.
The American Journal of Medicine
|
May 1, 1980
Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study
R J Meyer, P P Ferreira, J Cuttner, et al.
The American Journal of Medicine
|
October 1, 1980
Association of monocytic leukemia in patients with extreme leukocytosis
J Cuttner, M S Conjalka, M Reilly, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1987
Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications
C K Williams, J Cuttner, T Ohnuma, et al.
Page
of 9